﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Preventive Epidemiology</JournalTitle>
      <Issn>2476-3934</Issn>
      <Volume>8</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>10</Month>
        <DAY>07</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Collapsing glomerulopathy following COVID 19 infection; a mini-review to the recent data</ArticleTitle>
    <FirstPage>e35223</FirstPage>
    <LastPage>e35223</LastPage>
    <ELocationID EIdType="doi">10.34172/jpe.2023.35223</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Alem</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1903-9517</Identifier>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Farahmandsadr</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1890-5839</Identifier>
      </Author>
      <Author>
        <FirstName>Azadeh</FirstName>
        <LastName>Khayyat</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1867-1609</Identifier>
      </Author>
      <Author>
        <FirstName>Mohammad Ali</FirstName>
        <LastName>Esmaeil Pour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0393-3928</Identifier>
      </Author>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Nasri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1673-5741</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jpe.2023.35223</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>05</Month>
        <Day>20</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>07</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <Abstract>Collapsing glomerulopathy has been delineated as the most common morphological feature in COVID-19 individuals presenting with rapidly progressive renal failure and massive proteinuria. This condition, also known as COVID-19-associated nephropathy, has a poor prognosis. In COVID-19-related collapsing glomerulopathy, an immune dysfunction-mediated "second hit" to podocytes of African origin with APOL1 risk alleles was suggested. However, further research is still required to clarify this aspect of glomerulopathy.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">COVID-19</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Focal segmental glomerulosclerosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">SARS-CoV-2</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">COVID-19 associated nephropathy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Podocytes</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Glomerulosclerosis</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>